Pelvic exenteration for recurrent endometrial adenocarcinoma a retrospective multi-institutional study about 21 patients

Vito Chiantera, Martina Rossi, Pierandrea De Iaco, Christardt Koehler, Simone Marnitz, Valerio Gallotta, Alessandro Pasquale Margariti, Fabio Parazzini, Giovanni Scambia, Achim Schneider, Giuseppe Filiberto Vercellino

Research output: Contribution to journalArticle

Abstract

Objective: The aim of our study was to evaluate morbidity, mortality, and long-term survival of patients who underwent pelvic exenteration (PE) with curative intent for recurrence of endometrial adenocarcinoma during a single decade. Methods: We defined a cohort of 21 patients who met our inclusion criteria, referred to 4 cooperating gynecologic oncology settings in Germany and Italy between 2000 and 2011.Data regarding surgery, histology, and oncologic outcomeswere collected and statistically evaluated. Survival was determined from the day of exenteration until the last follow-up or death. Results: The median age was 66 years. A total of 42.9% of the patients had major complications, and a complete resection was achieved in 85.7% of the patients. A total of 71.4% of the patients had negative nodes. No patient died intraoperatively. The perioperative mortality, calculated within 30 days from PE, was 4.8%. The overall 5-year survival rate, evaluated using the Kaplan-Meier method, was 40%. For the subgroup with complete resection and negative lymph nodes, overall survival reached 60%. Conclusions: Despite a high complication rate, PE for solitary pelvic recurrence of endometrial cancer yields a high rate of long-term survival.

Original languageEnglish
Pages (from-to)880-884
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume24
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Pelvic Exenteration
Adenocarcinoma
Survival
Recurrence
Mortality
Endometrial Neoplasms
Italy
Germany
Histology
Survival Rate
Lymph Nodes
Morbidity

Keywords

  • Morbidity
  • Pelvic exenteration
  • Recurrent endometrial cancer
  • Survival

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Medicine(all)

Cite this

Pelvic exenteration for recurrent endometrial adenocarcinoma a retrospective multi-institutional study about 21 patients. / Chiantera, Vito; Rossi, Martina; De Iaco, Pierandrea; Koehler, Christardt; Marnitz, Simone; Gallotta, Valerio; Margariti, Alessandro Pasquale; Parazzini, Fabio; Scambia, Giovanni; Schneider, Achim; Vercellino, Giuseppe Filiberto.

In: International Journal of Gynecological Cancer, Vol. 24, No. 5, 2014, p. 880-884.

Research output: Contribution to journalArticle

Chiantera, V, Rossi, M, De Iaco, P, Koehler, C, Marnitz, S, Gallotta, V, Margariti, AP, Parazzini, F, Scambia, G, Schneider, A & Vercellino, GF 2014, 'Pelvic exenteration for recurrent endometrial adenocarcinoma a retrospective multi-institutional study about 21 patients', International Journal of Gynecological Cancer, vol. 24, no. 5, pp. 880-884. https://doi.org/10.1097/IGC.0000000000000002
Chiantera, Vito ; Rossi, Martina ; De Iaco, Pierandrea ; Koehler, Christardt ; Marnitz, Simone ; Gallotta, Valerio ; Margariti, Alessandro Pasquale ; Parazzini, Fabio ; Scambia, Giovanni ; Schneider, Achim ; Vercellino, Giuseppe Filiberto. / Pelvic exenteration for recurrent endometrial adenocarcinoma a retrospective multi-institutional study about 21 patients. In: International Journal of Gynecological Cancer. 2014 ; Vol. 24, No. 5. pp. 880-884.
@article{97ed87b7874e4ef0a79122f4531c91ed,
title = "Pelvic exenteration for recurrent endometrial adenocarcinoma a retrospective multi-institutional study about 21 patients",
abstract = "Objective: The aim of our study was to evaluate morbidity, mortality, and long-term survival of patients who underwent pelvic exenteration (PE) with curative intent for recurrence of endometrial adenocarcinoma during a single decade. Methods: We defined a cohort of 21 patients who met our inclusion criteria, referred to 4 cooperating gynecologic oncology settings in Germany and Italy between 2000 and 2011.Data regarding surgery, histology, and oncologic outcomeswere collected and statistically evaluated. Survival was determined from the day of exenteration until the last follow-up or death. Results: The median age was 66 years. A total of 42.9{\%} of the patients had major complications, and a complete resection was achieved in 85.7{\%} of the patients. A total of 71.4{\%} of the patients had negative nodes. No patient died intraoperatively. The perioperative mortality, calculated within 30 days from PE, was 4.8{\%}. The overall 5-year survival rate, evaluated using the Kaplan-Meier method, was 40{\%}. For the subgroup with complete resection and negative lymph nodes, overall survival reached 60{\%}. Conclusions: Despite a high complication rate, PE for solitary pelvic recurrence of endometrial cancer yields a high rate of long-term survival.",
keywords = "Morbidity, Pelvic exenteration, Recurrent endometrial cancer, Survival",
author = "Vito Chiantera and Martina Rossi and {De Iaco}, Pierandrea and Christardt Koehler and Simone Marnitz and Valerio Gallotta and Margariti, {Alessandro Pasquale} and Fabio Parazzini and Giovanni Scambia and Achim Schneider and Vercellino, {Giuseppe Filiberto}",
year = "2014",
doi = "10.1097/IGC.0000000000000002",
language = "English",
volume = "24",
pages = "880--884",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Pelvic exenteration for recurrent endometrial adenocarcinoma a retrospective multi-institutional study about 21 patients

AU - Chiantera, Vito

AU - Rossi, Martina

AU - De Iaco, Pierandrea

AU - Koehler, Christardt

AU - Marnitz, Simone

AU - Gallotta, Valerio

AU - Margariti, Alessandro Pasquale

AU - Parazzini, Fabio

AU - Scambia, Giovanni

AU - Schneider, Achim

AU - Vercellino, Giuseppe Filiberto

PY - 2014

Y1 - 2014

N2 - Objective: The aim of our study was to evaluate morbidity, mortality, and long-term survival of patients who underwent pelvic exenteration (PE) with curative intent for recurrence of endometrial adenocarcinoma during a single decade. Methods: We defined a cohort of 21 patients who met our inclusion criteria, referred to 4 cooperating gynecologic oncology settings in Germany and Italy between 2000 and 2011.Data regarding surgery, histology, and oncologic outcomeswere collected and statistically evaluated. Survival was determined from the day of exenteration until the last follow-up or death. Results: The median age was 66 years. A total of 42.9% of the patients had major complications, and a complete resection was achieved in 85.7% of the patients. A total of 71.4% of the patients had negative nodes. No patient died intraoperatively. The perioperative mortality, calculated within 30 days from PE, was 4.8%. The overall 5-year survival rate, evaluated using the Kaplan-Meier method, was 40%. For the subgroup with complete resection and negative lymph nodes, overall survival reached 60%. Conclusions: Despite a high complication rate, PE for solitary pelvic recurrence of endometrial cancer yields a high rate of long-term survival.

AB - Objective: The aim of our study was to evaluate morbidity, mortality, and long-term survival of patients who underwent pelvic exenteration (PE) with curative intent for recurrence of endometrial adenocarcinoma during a single decade. Methods: We defined a cohort of 21 patients who met our inclusion criteria, referred to 4 cooperating gynecologic oncology settings in Germany and Italy between 2000 and 2011.Data regarding surgery, histology, and oncologic outcomeswere collected and statistically evaluated. Survival was determined from the day of exenteration until the last follow-up or death. Results: The median age was 66 years. A total of 42.9% of the patients had major complications, and a complete resection was achieved in 85.7% of the patients. A total of 71.4% of the patients had negative nodes. No patient died intraoperatively. The perioperative mortality, calculated within 30 days from PE, was 4.8%. The overall 5-year survival rate, evaluated using the Kaplan-Meier method, was 40%. For the subgroup with complete resection and negative lymph nodes, overall survival reached 60%. Conclusions: Despite a high complication rate, PE for solitary pelvic recurrence of endometrial cancer yields a high rate of long-term survival.

KW - Morbidity

KW - Pelvic exenteration

KW - Recurrent endometrial cancer

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84904109620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904109620&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000002

DO - 10.1097/IGC.0000000000000002

M3 - Article

C2 - 24685828

AN - SCOPUS:84904109620

VL - 24

SP - 880

EP - 884

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 5

ER -